Florian Lordick, Oncologist, Professor of Medicine at the University of Leipzig, Head of Medical Oncology, Director of the Comprehensive Cancer Center Central Germany, shared on LinkedIn:
“Looking forward to speak 13th NOV 2027 at the McGill and the Université de Montréal joint visiting speaker in oncology program (VSPO).
Also, I look immensely forward to be part of Prof. Lorenzo Ferri Symposium on Upper Gastrointestinal Cancers at McGill 14th NOV 2027.
I hope to see many of my dear Canadian and international friends and colleagues – it is a wonderful community.
Annual Symposium on Upper Gastro-Intestinal Cancers | Division of Thoracic and Upper Gastrointestinal Surgery – McGill University.”
Visiting Speakers Program in Oncology (VSPO)
The Visiting Speakers Program in Oncology – VSPO is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Presentation Title: Advances in Upper GI Oncology: Biomarker-Driven Therapy in Gastric Cancer and Emerging RAS-Targeted Strategies in Pancreatic Cancer
Learning Objectives:
Provide residents, fellows and medical oncologists with an update on rapidly evolving therapeutic strategies in upper GI cancers, emphasizing:
- Biomarker-driven treatment of gastric cancer
- Emerging RAS-targeted approaches in pancreatic cancer.
Event Details:
- Date: Friday, November 13, 2026
- Location: MUHC
- Time: 15:00–17:00 EST
- Room: DS1.1427
Live on the Web!
Educational Grant Supporters:
AbbVie, Amgen, Astellas, AstraZeneca, BeOne, Bristol-Myers Squibb, Eisai, Eli Lilly Canada, EMD Serono, Forus Therapeutics, Gilead, GlaxoSmithKline (GSK), Ipsen Canada, Janssen, Merck, Pfizer, Roche, Sanofi, Seagen Canada, Servier, Taiho Pharma, Takeda, Viatris Canada.
About the Symposium
The Annual Symposium on Upper Gastro-Intestinal Cancers is a scientific meeting organized by McGill University in Montreal, Canada. It brings together specialists, researchers and healthcare professionals working in the field of upper GI cancers, particularly esophageal and gastric cancers.
The event offers an opportunity to share research findings, discuss recent developments in cancer treatment and exchange experiences on how new approaches can improve patient care.
Main objectives
The symposium aims to:
- Present the latest research and developments in esophageal and gastric cancer.
- Discuss new advances in medical and surgical oncology.
- Explore emerging treatment options and multidisciplinary approaches to cancer care.
- Improve patient outcomes through collaboration between different medical specialties.
- Promote knowledge exchange and research collaboration among local and international experts.
Read more articles featuring Florian Lordick on OncoDaily.
